Dr. Ahmed Elkamhawy is an experienced Pharmaceutical/Bioorganic Chemist & an Academic Pharmacist. He has over 15 years of hands-on experience designing, synthesizing, and developing new small molecules (organic compounds) for pharmaceutical use. His research investigates organic chemical reactions, structure-activity relationships of synthesized molecules, and drug discovery principles. He explores drug mechanisms of action and the relationship between chemical structure and biological activity to enhance drug candidates' potency, selectivity, and safety.
Dr. Ahmed has secured five international research projects totaling around $50K as a Principal Investigator from government grants in South Korea and Egypt. With a track record of publishing in top peer-reviewed journals, attending international conferences, and serving as an Editorial Board Member, Review Editor, Guest Editor, and Reviewer for various journals, he has published over 60 research publications with more than 1000 Citations. His expertise spans multiple fields including Pharmaceutical Organic Chemistry, Bioorganic Chemistry, Pharmacology & Pharmacy, Biochemistry & Molecular Biology, Medicinal Chemistry, and Life Sciences & Biomedicine. His i10-index stands at 35, with h-index value of 21 by Scopus, Google Scholar, and ResearchGate. He has extensive experience mentoring junior scientists, supervising postgraduate students, and teaching undergraduate/graduate classes, prioritizing clear communication, active learning, and connecting lessons to future careers. Advocating for student involvement in research, he has chaired and served on committees evaluating master's and Ph.D. dissertations at Dongguk University in South Korea before joining Nazarbayev University.
Dr. Ahmed thinks working together on research is important for making big scientific discoveries, getting more done in research, coming up with new ideas, and sharing knowledge and technology. He has teamed up with researchers from all over the world, including Italy, the USA, Saudi Arabia, the UK, South Korea, Egypt, Morocco, UAE, Finland, and South Africa.
Dr. Ahmed's research interests include but not limited to: - Development of new anticancer drug candidates - Design of novel hybrid heterocycles with antibacterial biological target - Studying Kinase inhibitors for cancer disorders - Free radical scavengers as drug candidates - New Pharmaceutical agents for Alzheimer's and Parkinson diseases - Natural products as anti-inflammatory agents - Computer-Aided Drug Design